1 / 23

The Global Health Network

The Global Health Network. Sourcing, Preparing and Accounting for Investigational Products. Nicky Kramer and Wynand Smythe 19TH SEPTEMBER 2014. IMP/IP. IMP (Investigational Medicinal Product) / IP (Investigational Product ) Sourcing and Receipt Storage Dispensing/Blinding

ashton-larsen
Download Presentation

The Global Health Network

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Global Health Network Sourcing, Preparing and Accounting for Investigational Products Nicky Kramer and Wynand Smythe 19TH SEPTEMBER 2014

  2. IMP/IP IMP (Investigational Medicinal Product) / IP (Investigational Product) Sourcing and Receipt Storage Dispensing/Blinding Randomisation Disposal/Destruction UCT CLINICAL RESEARCH CENTRE | IMP MANAGEMENT | GHTSA WORKSHOP | 19 SEP 2014

  3. IMP/IP IMP (Investigational Medicinal Product) / IP (Investigational Product) Sourcing and Receipt Storage Dispensing/Blinding Randomisation Disposal/Destruction UCT CLINICAL RESEARCH CENTRE | IMP MANAGEMENT | GHTSA WORKSHOP | 19 SEP 2014

  4. Sourcing and Receipt • Sponsor-driven Phase I: • New IMP & Formulation • Sponsor arranges manufacture • Importing • Dummy Dispensing • Investigator-led Phase III: • Typically Locally-Marketed Product • Pharmacist sources IMP • Dummy Dispensing Source of Accountability: Delivery waybills, Prescriptions, Invoices, Receipt Accountability UCT CLINICAL RESEARCH CENTRE | IMP MANAGEMENT | GHTSA WORKSHOP | 19 SEP 2014

  5. Receipt Accountability Sourcing and Receipt • Sponsor-driven Phase I: • New IMP & Formulation • Sponsor arranges manufacture • Importing • Dummy Dispensing • Investigator-led Phase III: • Typically Locally-Marketed Product • Pharmacist sources IMP • Dummy Dispensing Source of Accountability: Delivery waybills, Prescriptions, Invoices, Receipt Accountability

  6. IMP/IP IMP (Investigational Medicinal Product) / IP (Investigational Product) Sourcing and Receipt Storage Dispensing/Blinding Randomisation Disposal/Destruction UCT CLINICAL RESEARCH CENTRE | IMP MANAGEMENT | GHTSA WORKSHOP | 19 SEP 2014

  7. Storage • Certificate of Analysis (COA) •  light, temperature, humidity • Rigorous Control •  E.g. fridges, air-con, probes, light protection • Unique Storage Space • Back-Up Plan Sources of Accountability: Temperature Logs, Calibration Certificates, SOPs, COAs UCT CLINICAL RESEARCH CENTRE | IMP MANAGEMENT | GHTSA WORKSHOP | 19 SEP 2014

  8. IMP/IP IMP (Investigational Medicinal Product) / IP (Investigational Product) Sourcing and Receipt Storage Dispensing/Blinding Randomisation Disposal/Destruction UCT CLINICAL RESEARCH CENTRE | IMP MANAGEMENT | GHTSA WORKSHOP | 19 SEP 2014

  9. Dispensing • Dispensing Licence • Expiry Dates • IP prep (e.g. reconstitution, infusion) • Labelling requirements •  e.g. Participant ID, Study/Protocol/Investigator ID, Quantity Dispensed, Mode of Delivery, Storage Condition, Exp./Lot/Batch #’s • Blinding – implication for dispensing directly to patient • Unblinding procedure Source of accountability: MCC documentation, Pharmacy Manual (accountability, labels, patient dispensing logs) UCT CLINICAL RESEARCH CENTRE | IMP MANAGEMENT | GHTSA WORKSHOP | 19 SEP 2014

  10. Store Accountability Sourcing and Receipt • Sponsor-driven Phase I: • New IMP & Formulation • Sponsor arranges manufacture • Importing • Dummy Dispensing • Investigator-led Phase III: • Typically Locally-Marketed Product • Pharmacist sources IMP • Dummy Dispensing Source of Accountability: Delivery waybills, Prescriptions, Invoices, Receipt Accountability

  11. IMP/IP IMP (Investigational Medicinal Product) / IP (Investigational Product) Sourcing and Receipt Storage Dispensing/Blinding Randomisation Disposal/Destruction UCT CLINICAL RESEARCH CENTRE | IMP MANAGEMENT | GHTSA WORKSHOP | 19 SEP 2014

  12. Randomisation • Treatment Allocation/Dispensing • Generated by statistician/pharmacist (sponsor or site produced), stored in secure location e.g. pharmacy file •  Randomisation schedule or Automated system e.g. IVRS • Randomisation log Source of accountability: Randomisation schedule and Randomisation logs UCT CLINICAL RESEARCH CENTRE | IMP MANAGEMENT | GHTSA WORKSHOP | 19 SEP 2014

  13. Randomisation Schedule Accountability Sourcing and Receipt • Sponsor-driven Phase I: • New IMP & Formulation • Sponsor arranges manufacture • Importing • Dummy Dispensing • Investigator-led Phase III: • Typically Locally-Marketed Product • Pharmacist sources IMP • Dummy Dispensing Source of Accountability: Delivery waybills, Prescriptions, Invoices, Receipt Accountability

  14. Randomisation Log Accountability Sourcing and Receipt Randomization Log for: PLACEBO FOR IMP Randomization Log for: ACTIVE IMP • Sponsor-driven Phase I: • New IMP & Formulation • Sponsor arranges manufacture • Importing • Dummy Dispensing • Investigator-led Phase III: • Typically Locally-Marketed Product • Pharmacist sources IMP • Dummy Dispensing Source of Accountability: Delivery waybills, Prescriptions, Invoices, Receipt Accountability

  15. IMP/IP IMP (Investigational Medicinal Product) / IP (Investigational Product) Sourcing and Receipt Storage Dispensing/Blinding Randomisation Disposal/Destruction UCT CLINICAL RESEARCH CENTRE | IMP MANAGEMENT | GHTSA WORKSHOP | 19 SEP 2014

  16. Return/disposal • At conclusion of study, final inventory and reconciliation • Sponsor-driven: return to sponsor for disposal or site arranges disposal • Arrange with waste disposal company Source of accountability: Disposal/Destruction Log UCT CLINICAL RESEARCH CENTRE | IMP MANAGEMENT | GHTSA WORKSHOP | 19 SEP 2014

  17. Destruction Log Accountability Sourcing and Receipt • Sponsor-driven Phase I: • New IMP & Formulation • Sponsor arranges manufacture • Importing • Dummy Dispensing • Investigator-led Phase III: • Typically Locally-Marketed Product • Pharmacist sources IMP • Dummy Dispensing Source of Accountability: Delivery waybills, Prescriptions, Invoices, Receipt Accountability

  18. SUMMARY • Importance of pharmacy role: maintains accountability of IMP from start to finish, ensuring right dose given to right patient at the right time • Accountability is a continuous process from start of study until closure • Inform/involve pharmacy at the outset • Resources available on CRC website - http://www.crc.uct.ac.za/ UCT CLINICAL RESEARCH CENTRE | IMP MANAGEMENT | GHTSA WORKSHOP | 19 SEP 2014

  19. SUMMARY • Importance of pharmacy role: maintains accountability of IMP from start to finish, ensuring right dose given to right patient at the right time • Accountability is a continuous process from start of study until closure • Inform/involve pharmacy at the outset • Resources available on CRC website - http://www.crc.uct.ac.za/

  20. Questions? | IMP MANAGEMENT | GHTSA WORKSHOP | 19 SEP 2014

More Related